European Clinical-Stage Biopharma Prepares for a Nasdaq IPO

A clinical-stage biopharmaceutical company headquartered in Europe engaged Danforth Advisors to prepare for its Nasdaq IPO and the launch of US operations. Danforth provided strategic C-level advisory, and built and managed the company’s US business functions – scaling resources in line with several key events, including the eventual IPO, rapid period of hiring, and initiation of multiple global clinical studies.

By partnering with Danforth, the company was able to outsource and integrate multiple functions under one roof – gaining the breadth of our institutional knowledge and capabilities in an efficient, variable way.

Variable Capabilities Evolve with Company Needs

Case Study Graphic European Biopharma
  • Resources were dialed up and down as needed, avoiding a high fixed headcount.
  • Precise skill sets supported corporate milestones, including IPO preparation and initiation of clinical trials.
  • *Client was able to leverage more resources for the cost as compared to FTE equivalent in hours/month.
View the complete case study